Blog
About

0
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      The Effect of Baseline Rescue Medication Use on Efficacy and Safety of Nebulized Glycopyrrolate Treatment in Patients with COPD from the GOLDEN 3 and 4 Studies [Corrigendum]

      International Journal of Chronic Obstructive Pulmonary Disease

      Dove

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Donohue JF, Ozol-Godfrey A, Goodin T, Sanjar S. Int J Chron Obstruct Pulmon Dis. 2020;15:745–754. The authors have advised there is an error in Figure 4 on page 751. The Q2 subgroup of the placebo arm has the label of “−0.012” which should read “0.012”. The correct Figure 4 is shown below. The authors apologize for this error. Figure 4 Pooled analysis of change from baseline in trough FEV1 at 12 weeks by baseline rescue medication use subgroup (ITT population). Notes: *p<0.05, **p<0.01, ***p<0.001 versus placebo; n-values represent the number of patients with on-treatment data at week 12. Abbreviations: BID, twice daily; FEV1, forced expiratory volume in 1 second; GLY, nebulized glycopyrrolate; ITT, intent-to-treat; LS, least squares; Q, quarter; SE, standard error.

          Related collections

          Author and article information

          Journal
          Int J Chron Obstruct Pulmon Dis
          Int J Chron Obstruct Pulmon Dis
          COPD
          copd
          International Journal of Chronic Obstructive Pulmonary Disease
          Dove
          1176-9106
          1178-2005
          26 May 2020
          2020
          26 May 2020
          : 15
          : 1177
          Article
          262956
          10.2147/COPD.S262956
          7267784
          © 2020 Donohue et al.

          This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.php).

          Page count
          Figures: 1, Pages: 1
          Categories
          Corrigendum

          Respiratory medicine

          Comments

          Comment on this article